DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: ZINGO

Summary for Tradename: ZINGO

Patents:5
Applicants:1
NDAs:1
Suppliers: see list1
drug
patent expirations by year for
 ZINGO

Pharmacology for Tradename: ZINGO

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia

Clinical Trials for: ZINGO

Tumescent Lidocaine Maximum Safe mg/kg Dosage
Status: Enrolling by invitation Condition: Anesthesia

The Effect of Intravenous Lidocaine and Intraperitoneal Lidocaine Irrigation on Pain After Laparoscopic Cholecystectomy
Status: Recruiting Condition: Postoperative Pain

Lidocaine: Effect of Lidocaine in Chronic Cough
Status: Completed Condition: Chronic Cough

A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
Status: Completed Condition: Postherpetic Neuralgia; Diabetic Neuropathy; Complex Regional Pain Syndrome; Carpal Tunnel Syndrome; HIV Neuropathy; Idiopathic Sensory Neuropathy; Peripheral Neuropathy

J-Tip® Jet Injection of 1% Buffered Lidocaine or Saline Versus 4% Lidocaine Cream Before Venipuncture or IV Insertion
Status: Terminated Condition: Pain

Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving
Status: Not yet recruiting Condition: Cocaine Addiction

Evaluation of the Depth and Duration of Anesthesia From Heated Lidocaine/Tetracaine (Synera®) Patches Compared With 5% Lidocaine (Lidoderm®) Patches Applied to Healthy Adult Volunteers
Status: Completed Condition: Healthy

A Dose-response Study of Lidocaine and Etomidate
Status: Completed Condition: Etomidate Overdose of Undetermined Intent

Effect of Intravenous Lidocaine and Dexamethasone Combination on Postoperative Sore Throat, Cough and Hoarseness.
Status: Recruiting Condition: Postoperative Sore Throat, Cough, Hoarseness

A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)
Status: Completed Condition: Morton's Neuroma

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114Aug 16, 2007DISCNNo5,630,796<disabled><disabled>
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114Aug 16, 2007DISCNNo5,899,880<disabled>Y<disabled>
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114Aug 16, 2007DISCNNo6,004,286<disabled>Y<disabled>
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114Aug 16, 2007DISCNNo6,881,200<disabled>Y<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc